Back to TD ASSET MANAGEMENT INC TD ASSET MANAGEMENT INC

MLTXMLTX
17 quarters

Position history for TD ASSET MANAGEMENT INCTD ASSET MANAGEMENT INC's holdings in MoonLake Immunotherapeutics Class A

TD ASSET MANAGEMENT INC holds 128,274 shares of MLTX (MoonLake Immunotherapeutics Class A), worth $2.5M as of 2026-Q2. The position was decreased (-10.1% shares). MLTX represents 0.0% of TD ASSET MANAGEMENT INC's portfolio.

Current Value

$2.5M

Current Shares

128,274

Total Value Change

+$2.3M

Total Shares Change

+99,308

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
128,274
-10.1%
$2.5M0.0%$19.47
0
2026-Q1
Increased
142,706
+12.6%
$2.7M0.0%$17.69
30
2025-Q4
Increased
126,744
+18.9%
$1.7M0.0%$13.21
30
2025-Q3
Decreased
106,610
-42.7%
$764,3940.0%$6.24
0
2025-Q2
Decreased
186,152
-14.2%
$8.8M0.0%$47.52
0
2025-Q1
Decreased
216,904
-17.1%
$8.5M0.0%$39.86
0
2024-Q4
Increased
261,634
+21.2%
$14.2M0.0%$53.02
34
2024-Q3
Increased
215,834
+3.1%
$10.7M0.0%$49.40
29
2024-Q2
Increased
209,234
+2.5%
$9.2M0.0%$43.97
28
2024-Q1
Decreased
204,094
-2.4%
$10.3M0.0%$50.23
0
2023-Q4
Increased
209,142
+4.4%
$12.6M0.0%$60.39
29
2023-Q3
Increased
200,390
+101.1%
$11.4M0.0%$57.00
45
2023-Q2
Increased
99,640
+48.0%
$5.1M0.0%$51.08
37
2023-Q1
Unchanged
67,312
0.0%
$1.4M0.0%$21.85
0
2022-Q4
Unchanged
67,312
0.0%
$706,7760.0%$10.50
0
2022-Q3
Increased
67,312
+132.4%
$538,0000.0%$7.98
39
2022-Q2
New
28,966
-
$152,0000.0%$5.00
31

Other major holders of MLTX: FMR LLC, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used